Isik, D.; Alan, Ö.; Akdağ, G.; Yildirim, S.; Kınıkoğlu, O.; Altintas, Y.E.; Turkoglu, E.; Surmeli, H.; Basoglu, T.; Sever, O.N.;
et al. Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older. J. Clin. Med. 2024, 13, 6263.
https://doi.org/10.3390/jcm13206263
AMA Style
Isik D, Alan Ö, Akdağ G, Yildirim S, Kınıkoğlu O, Altintas YE, Turkoglu E, Surmeli H, Basoglu T, Sever ON,
et al. Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older. Journal of Clinical Medicine. 2024; 13(20):6263.
https://doi.org/10.3390/jcm13206263
Chicago/Turabian Style
Isik, Deniz, Özkan Alan, Goncagül Akdağ, Sedat Yildirim, Oğuzcan Kınıkoğlu, Yunus Emre Altintas, Ezgi Turkoglu, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever,
and et al. 2024. "Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older" Journal of Clinical Medicine 13, no. 20: 6263.
https://doi.org/10.3390/jcm13206263
APA Style
Isik, D., Alan, Ö., Akdağ, G., Yildirim, S., Kınıkoğlu, O., Altintas, Y. E., Turkoglu, E., Surmeli, H., Basoglu, T., Sever, O. N., Odabas, H., Yildirim, M. E., & Turan, N.
(2024). Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older. Journal of Clinical Medicine, 13(20), 6263.
https://doi.org/10.3390/jcm13206263
